1. King CS and Nathan SD. Lancet Respir Med 2017;5:72–84.
2. Richeldi L et al. N Engl J Med 2014;370:2071–82.
3. Richeldi L et al. N Engl J Med 2011;365:1079–87.
4. Maher TM et al. Lancet Respir Med 2019;7:771–79.
5. Lancaster L et al. Am J Respir Crit Care Med 2018;197:A4266.

These trials were funded by Boehringer Ingelheim. Editorial and formatting assistance, supported financially by Boehringer Ingelheim, was provided by Elizabeth Ng and Wendy Morris of FleishmanHillard Fishburn, London, UK during preparation of this poster. The authors were fully responsible for all content and editorial decisions, were involved at all stages of poster development and have approved the final version. Boehringer Ingelheim was given the opportunity to review the poster for medical and scientific accuracy as well as intellectual property considerations. The authors received no direct compensation related to the development of this poster. Ian Glaspole reports fees as a speaker/advisory board member from Boehringer Ingelheim, Roche, Menarini, Ad Alta, and Pulmotect. Elisabeth Bendstrup has received unrestricted grants and personal fees as a speaker and advisory board member from Boehringer Ingelheim, Roche, AstraZeneca, and GlaxoSmithKline.